Anticancer agent containing dendritic cell having RNA virus transferred thereinto

It is intended to provide an anticancer agent which contains a dendritic cell having an RNA virus transferred thereinto; a process for producing an anticancer agent which comprises the step of producing a dendritic cell having an RNA virus transferred thereinto; a method of treating cancer by using...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	SHIBATA SATOKO,HASEGAWA MAMORU,KONDO HARUHIKO,SUEISHI KATSUO,OKANO SHINJI,YONEMITSU YOSHIKAZU
Format:	Patent
Sprache:	eng
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	It is intended to provide an anticancer agent which contains a dendritic cell having an RNA virus transferred thereinto; a process for producing an anticancer agent which comprises the step of producing a dendritic cell having an RNA virus transferred thereinto; a method of treating cancer by using a dendritic cell having an RNA virus transferred thereinto; and a method of effectively treating cancer by combining an RNA virus with a dendritic cell.